Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 18, 2018 - The FDA announced that serious cases of neural tube birth defects have been reported in babies born to women treated with dolutegravir.
Download PDF
Return to publications
